• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2023年中国沈阳肺结核疾病负担评估

Evaluation of pulmonary tuberculosis disease burden in Shenyang, China, 2023.

作者信息

Chen Huijie, Bi Haiyan, Li Peng, Yang Zhixing, Wen Lihai, Sun Baijun, Sun Wei

机构信息

Department of Infectious Disease, Shenyang Municipal Center for Disease Control and Prevention(Shenyang Municipal Health Supervision Institute), Shenyang, 110623, Liaoning Province, China.

Key Laboratory of Early Warning and Intervention Technologies and Countermeasures for Major Public Health Events in Liaoning Province, China Medical University, Shenyang, 110122, Liaoning Province, China.

出版信息

BMC Infect Dis. 2025 Feb 4;25(1):166. doi: 10.1186/s12879-025-10572-8.

DOI:10.1186/s12879-025-10572-8
PMID:39905313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11796274/
Abstract

BACKGROUND

Pulmonary tuberculosis (PTB) is one of the most serious infectious diseases worldwide and poses a great threat to people's health. China has a vast territory with substantial regional disparities in the PTB disease burden. However, there have been no studies conducted to evaluate the PTB disease burden in Shenyang. The aim was to elucidate the magnitude, composition, and distribution of PTB disease burden in Shenyang.

METHODS

The disability-adjusted life years (DALYs) calculated based on Global Burden of Disease (GBD) framework was used to assess the disease burden of PTB in Shenyang in 2023, and descriptive epidemiological methods were employed to elucidate the magnitude, composition, and distribution characteristics of PTB disease burden in Shenyang.

RESULTS

In 2023, 4,169 PTB cases were reported in Shenyang, including 2,901 males and 1,268 females. The incidence of PTB was 45.50/10, of which 64.29/10 for males and 27.30/10 for females. The incidence among males was higher than that among females (X = 688.56, p<0.001). The highest incidence was 107.00/10 in the group of the population aged 80 and above (X = 1171.75, p<0.001). In 2023, 189 PTB deaths were reported in Shenyang, including 156 males and 33 females. The mortality of PTB was 2.06/10 of which 3.46/10 for males and 0.71/10 for females. The mortality among males was higher than that among females (X = 83.69, p<0.001). The highest mortality was 16.04/10 in the group of the population aged 80 and above (X = 285.61, p<0.001). The PTB DALYs rate was 58.25/10, of which 91.73/10 for males and 21.22/10 for females. The DALYs rate among males was higher than that among females (X = 44.04, p<0.001). The highest DALYs rate was 149.86/10 in the group of the population aged 80 and above (X = 305.35, p<0.001). Years of life lost (YLLs) due to PTB accounted for 71.38% of total DALYs, of which 74.33% for males and 52.89% for females.

CONCLUSION

The PTB DALYs rate in Shenyang was 58.25/10, which was lower than that in China, equivalent to 80% of the national PTB disease burden rate. The disease burden showed a characteristic of increasing with age, and the PTB DALYs rate for males was higher than that for females, being equivalent to 4 times the female rate. The predominant disease burden of PTB was attributed to YLLs, accounting for as much as 71.38%, indicating that PTB primarily results in premature mortality rather than disability. Therefore, the focus should be shifted towards early intervention to reduce transmission, especially for the aged males.

摘要

背景

肺结核(PTB)是全球最严重的传染病之一,对人们的健康构成巨大威胁。中国地域辽阔,肺结核疾病负担存在显著的地区差异。然而,尚未有研究对沈阳的肺结核疾病负担进行评估。本研究旨在阐明沈阳肺结核疾病负担的规模、构成和分布情况。

方法

基于全球疾病负担(GBD)框架计算的伤残调整生命年(DALYs)用于评估2023年沈阳肺结核的疾病负担,并采用描述性流行病学方法阐明沈阳肺结核疾病负担的规模、构成和分布特征。

结果

2023年,沈阳报告肺结核病例4169例,其中男性2901例,女性1268例。肺结核发病率为45.50/10万,其中男性为64.29/10万,女性为27.30/10万。男性发病率高于女性(X² = 688.56,p<0.001)。80岁及以上人群组发病率最高,为107.00/10万(X² = 1171.75,p<0.001)。2023年,沈阳报告肺结核死亡189例,其中男性156例,女性33例。肺结核死亡率为2.06/10万,其中男性为3.46/10万,女性为0.71/10万。男性死亡率高于女性(X² = 83.69,p<0.001)。80岁及以上人群组死亡率最高,为16.04/10万(X² = 285.61,p<0.001)。肺结核伤残调整生命年率为58.25/10万,其中男性为91.73/10万,女性为21.22/10万。男性伤残调整生命年率高于女性(X² = 44.04,p<0.001)。80岁及以上人群组伤残调整生命年率最高,为149.86/10万(X² = 305.35,p<0.001)。因肺结核导致的寿命损失年(YLLs)占总伤残调整生命年的71.38%,其中男性为74.33%,女性为52.89%。

结论

沈阳肺结核伤残调整生命年率为58.25/10万,低于全国水平,相当于全国肺结核疾病负担率的80%。疾病负担呈现随年龄增长的特征,男性肺结核伤残调整生命年率高于女性,相当于女性的4倍。肺结核的主要疾病负担归因于寿命损失年,占比高达71.38%,表明肺结核主要导致过早死亡而非残疾。因此,应将重点转向早期干预以减少传播,特别是针对老年男性。

相似文献

1
Evaluation of pulmonary tuberculosis disease burden in Shenyang, China, 2023.2023年中国沈阳肺结核疾病负担评估
BMC Infect Dis. 2025 Feb 4;25(1):166. doi: 10.1186/s12879-025-10572-8.
2
The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.1990 - 2021年美国各州疾病、伤害及风险因素负担:《2021年全球疾病负担研究》的系统分析
Lancet. 2024 Dec 7;404(10469):2314-2340. doi: 10.1016/S0140-6736(24)01446-6.
3
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家 204 个地区 1990-2019 年 12 种精神障碍疾病的负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10.
4
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
5
Global and China burden of hormone-related cancers and risk factors, 1990-2021: results from the Global Burden of Disease Study 2021.1990 - 2021年全球及中国激素相关癌症负担与风险因素:全球疾病负担研究2021结果
BMC Public Health. 2025 Apr 28;25(1):1566. doi: 10.1186/s12889-025-22768-3.
6
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
7
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.2019 年与 85 种病原体相关的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet Infect Dis. 2024 Aug;24(8):868-895. doi: 10.1016/S1473-3099(24)00158-0. Epub 2024 Apr 16.
8
Sex disparity in non-communicable disease burden in Iran from 1990 to 2021 based on the global burden of disease study.基于全球疾病负担研究的1990年至2021年伊朗非传染性疾病负担中的性别差异
Sci Rep. 2025 Mar 22;15(1):9969. doi: 10.1038/s41598-025-94015-z.
9
Tuberculosis disease burden in China: a spatio-temporal clustering and prediction study.中国结核病疾病负担:一项时空聚集与预测研究。
Front Public Health. 2025 Jan 7;12:1436515. doi: 10.3389/fpubh.2024.1436515. eCollection 2024.
10
Burden of COPD in Nepal.尼泊尔慢性阻塞性肺疾病的负担。
Int J Chron Obstruct Pulmon Dis. 2018 Feb 9;13:583-589. doi: 10.2147/COPD.S154319. eCollection 2018.

本文引用的文献

1
Effect of complicated, untreated and uncontrolled diabetes and pre-diabetes on treatment outcome among patients with pulmonary tuberculosis.复杂、未经治疗和控制的糖尿病及糖尿病前期对肺结核患者治疗结局的影响。
Respirology. 2024 Jul;29(7):624-632. doi: 10.1111/resp.14714. Epub 2024 Mar 27.
2
Changes in tuberculosis burden and its associated risk factors in Guizhou Province of China during 2006-2020: an observational study.2006-2020 年期间中国贵州省结核病负担及其相关危险因素的变化:一项观察性研究。
BMC Public Health. 2024 Feb 20;24(1):526. doi: 10.1186/s12889-024-18023-w.
3
Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India.成人肺结核患者的营养支持:在印度恰尔康得邦 RATIONS 试验中的一个方案性队列中的结局。
Lancet Glob Health. 2023 Sep;11(9):e1402-e1411. doi: 10.1016/S2214-109X(23)00324-8. Epub 2023 Aug 8.
4
Disease burden of tuberculosis and post-tuberculosis in Inner Mongolia, China, 2016-2018 - based on the disease burden of post-TB caused by COPD.2016-2018 年中国内蒙古地区结核病和结核后疾病负担——基于 COPD 导致的结核后疾病负担。
BMC Infect Dis. 2023 Jun 14;23(1):406. doi: 10.1186/s12879-023-08375-w.
5
Impaired pulmonary function and associated factors in the elderly with tuberculosis on admission: a preliminary report.入院老年肺结核患者肺功能受损及相关因素:初步报告。
BMC Infect Dis. 2023 Apr 19;23(1):251. doi: 10.1186/s12879-023-08183-2.
6
The global, regional, and national burden of tuberculosis in 204 countries and territories, 1990-2019.204 个国家和地区 1990-2019 年的全球、区域和国家结核病负担。
J Infect Public Health. 2023 Mar;16(3):368-375. doi: 10.1016/j.jiph.2023.01.014. Epub 2023 Jan 20.
7
Tuberculosis in an Aging World.老龄化世界中的结核病
Pathogens. 2022 Sep 26;11(10):1101. doi: 10.3390/pathogens11101101.
8
Age-Specific Pulmonary Tuberculosis Notification Rates - China, 2008-2018.2008 - 2018年中国特定年龄组肺结核报告发病率
China CDC Wkly. 2022 Sep 23;4(38):841-846. doi: 10.46234/ccdcw2022.176.
9
Clinical characteristics of COVID-19 in patients with tuberculosis and factors associated with the disease severity.COVID-19 患者中结核病的临床特征及与疾病严重程度相关的因素。
Int J Infect Dis. 2022 Nov;124 Suppl 1:S82-S89. doi: 10.1016/j.ijid.2022.04.041. Epub 2022 Apr 26.
10
Application of Disability-Adjusted Life Years to Evaluate the Burden and Trend of Tuberculosis - China, 1990-2019.应用伤残调整生命年评估1990 - 2019年中国结核病负担及趋势
China CDC Wkly. 2022 Mar 18;4(11):220-225. doi: 10.46234/ccdcw2022.051.